These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29246722)

  • 1. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
    Yu W; Tang C; Hobbs BP; Li X; Koay EJ; Wistuba II; Sepesi B; Behrens C; Rodriguez Canales J; Parra Cuentas ER; Erasmus JJ; Court LE; Chang JY
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1090-1097. PubMed ID: 29246722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis.
    Wu J; Aguilera T; Shultz D; Gudur M; Rubin DL; Loo BW; Diehn M; Li R
    Radiology; 2016 Oct; 281(1):270-8. PubMed ID: 27046074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer.
    Fave X; Zhang L; Yang J; Mackin D; Balter P; Gomez D; Followill D; Jones AK; Stingo F; Liao Z; Mohan R; Court L
    Sci Rep; 2017 Apr; 7(1):588. PubMed ID: 28373718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective external validation of radiomics-based predictive model of distant metastasis after dynamic tumor tracking stereotactic body radiation therapy in patients with non-small-cell lung cancer: A multi-institutional analysis.
    Adachi T; Nakamura M; Matsuo Y; Karasawa K; Kokubo M; Sakamoto T; Hiraoka M; Mizowaki T
    J Appl Clin Med Phys; 2024 Oct; 25(10):e14475. PubMed ID: 39178139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
    Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
    Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Franceschini D; Cozzi L; De Rose F; Navarria P; Fogliata A; Franzese C; Pezzulla D; Tomatis S; Reggiori G; Scorsetti M
    Strahlenther Onkol; 2020 Oct; 196(10):922-931. PubMed ID: 31722061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Regional Recurrence and Prognosis in Stereotactic Body Radiation Therapy-Treated Clinical Stage I Non-small Cell Lung Cancer Using a Radiomics Model Constructed With Surgical Data.
    Ni J; Chen H; Yu L; Guo T; Zhou Y; Jiang S; Ye R; Yang X; Chu L; Chu X; Li H; Liu W; Gu Y; Yuan Z; Gong J; Zhu Z
    Int J Radiat Oncol Biol Phys; 2024 Nov; 120(4):1096-1106. PubMed ID: 38936632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
    Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
    Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
    Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
    PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
    Huynh E; Coroller TP; Narayan V; Agrawal V; Hou Y; Romano J; Franco I; Mak RH; Aerts HJ
    Radiother Oncol; 2016 Aug; 120(2):258-66. PubMed ID: 27296412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
    Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
    Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
    Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
    Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics Signature: A Biomarker for the Preoperative Distant Metastatic Prediction of Stage I Nonsmall Cell Lung Cancer.
    Fan L; Fang M; Tu W; Zhang D; Wang Y; Zhou X; Xia Y; Li Z; Liu S
    Acad Radiol; 2019 Sep; 26(9):1253-1261. PubMed ID: 30527455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors.
    Fried DV; Mawlawi O; Zhang L; Fave X; Zhou S; Ibbott G; Liao Z; Court LE
    Radiology; 2016 Jan; 278(1):214-22. PubMed ID: 26176655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics.
    Wang X; Duan H; Li X; Ye X; Huang G; Nie S
    Phys Med Biol; 2020 Feb; 65(4):045006. PubMed ID: 31962301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.
    Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H
    Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of pre-therapy 2-deoxy-2-
    Arshad MA; Thornton A; Lu H; Tam H; Wallitt K; Rodgers N; Scarsbrook A; McDermott G; Cook GJ; Landau D; Chua S; O'Connor R; Dickson J; Power DA; Barwick TD; Rockall A; Aboagye EO
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):455-466. PubMed ID: 30173391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
    Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
    Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification and overall survival prediction in extensive stage small cell lung cancer after chemotherapy with immunotherapy based on CT radiomics.
    Wang F; Chen W; Chen F; Lu J; Xu Y; Fang M; Jiang H
    Sci Rep; 2024 Sep; 14(1):22659. PubMed ID: 39349536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.